Clinical Trial Update: A Study of Embeda (Kadian NT, ALO-01) in Subjects With Pain Due to Osteoarthritis of the Hip or Knee [Phase 3]

View source ↗

Summary

Pfizer completed a Phase 3 trial of Embeda (morphine/naltrexone extended-release) for pain due to osteoarthritis of the hip or knee; results were posted in Octo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• EMBEDA (morphine sulfate/naltrexone hydrochloride extended-release)

Snippet

Sponsor: Pfizer | Conditions: Osteoarthritis, Chronic Pain | Phase 3 | Status: COMPLETED | Results posted: 2009-10-30